Clinical outcomes following fractional flow reserve-guided revascularization using nicorandil versus conventional hyperemic agents: insights from the J-PRIDE Registry

Kazutaka Nogi(Nara Medical University), Daisuke Higashioka(Wakayama Medical University), Yukihiro Hashimoto(Nara Medical University), Kotaro Miyata(St. Luke's International Hospital), Yuetsu Kikuta(Imperial College London), Yoshihisa Kanaji(Tsuchiura Kyodo General Hospital), Hidenobu Terai(Kanazawa Hospital), Tomohiro Shinozaki(Department of Health), Jun Shiraishi(Osaka International Cancer Institute), Shoichi Kuramitsu(Kokura Memorial Hospital), Hiroki Okabe(University of Occupational and Environmental Health Japan), Toru Tagashira(Tokyo-Kita Medical Center), Yutaro Naka, Toru Morofuji, Atsushi Iwai(National Archives and Records Administration), Yoshiaki Kawase(Gifu Heart Center), Shungo Hikoso(Nara Medical University), Hidetaka Nishina(Tsukuba Medical Center Hospital), Yohei Yakuta(Ishikawa Prefectural Central Hospital), Umihiko Kaneko(Sapporo Science Center), Takayoshi Toba(Kobe University), Masashi Iwabuchi(Kindai University Hospital), Akinori Sugano(Ibaraki Prefectural Central Hospital), Kazunori Horie(Sendai Kousei Hospital), Hirohiko Ando(Aichi Medical University), T Kubo(Tokyo Medical University Hachioji Medical Center), Hirofumi Ohashi, Yasutsugu Shiono(Wakayama Medical University), Hiromasa Otake(Kobe University), on behalf of the J-PRIDE investigators, Tetsuya Amano(Kanazawa Hospital), Hitoshi Matsuo(Sapporo Science Center), Nobuhiro Tanaka(Tokyo Medical University Hachioji Medical Center), Futoshi Yamanaka(Shonan Kamakura General Hospital), Taku Asano(St. Luke's International Hospital), Yuki Nakashima, Tsunekazu Kakuta(Tsuchiura Kyodo General Hospital), Takashi Akasaka(Hyogo Brain and Heart Center), Shinichiro Yamada, Takenori Domei(Kokura Memorial Hospital), Hiroyoshi Yokoi, Tomoaki Ito
Cardiovascular Intervention and Therapeutics
June 6, 2026
Cited by 0


Related Papers